Once daily insulin glargine may induce loss of basal insulin action in some patients with type 1 diabetes receiving basal bolus regimens: The need for twice daily glargine?

被引：0
|
作者：
Idampitiya, C
Ward, K
Curtis, C
Fernando, DJS
Idris, I
Thomson, G
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A493 / A493
页数：1
相关论文
共 50 条
  • [31] Utilization of Twice Daily Dosing of Insulin Glargine in Type 2 Diabetes Mellitus
    Patel, Hansita
    Attridge, Rebecca L.
    Cauthon, Kimberly
    Horlen, Cheryl K.
    Urteaga, Elizabeth M.
    Witte, Amy
    PHARMACOTHERAPY, 2015, 35 (11): : E258 - E258
  • [32] INSULIN GLARGINE IN CRITICALLY ILL PATIENTS: ONCE-DAILY COMPARED TO TWICE-DAILY DOSING
    Fox, Marlena
    Perry, Melanie
    Liu-DeRyke, Xi
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 195 - 195
  • [33] Increased insulinization with once-dailyas compared to twice-daily insulin glargine in type 1 diabetes.
    Schroeder, E
    Clark, CD
    Burge, MR
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S86 - S86
  • [34] Comparison of treatment satisfaction of twice-daily BIAsp 70/30 with once-daily insulin glargine in patients with type 2 diabetes
    Brod, M
    Lammert, M
    Raskin, P
    DIABETES, 2005, 54 : A114 - A114
  • [35] Once-Daily Use of a New Generation Ultra-Long Acting Basal Insulin with a Bolus Boost in Insulin-Naive Subjects with Type 2 Diabetes: Comparison with Insulin Glargine
    Heise, Tim
    Tack, Cees
    Cuddihy, Bob Micheal
    Davidson, Jaime
    Gouet, Didier
    Liebl, Andreas
    Bobillo, Enrique Romero
    Mersebach, Henriette
    Dykiel, Patrik
    Jorde, Rolfe
    DIABETES, 2010, 59 : A9 - A10
  • [36] Once-daily use of a new generation ultra-long acting basal insulin with a bolus boost in insulin-naive people with type 2 diabetes: comparison with insulin glargine
    Cuddihy, R.
    Tack, C. J.
    Heise, T.
    Davidson, J.
    Gouet, D.
    Liebl, A.
    Romero, E.
    Mersebach, H.
    Dykiel, P.
    Jorde, R.
    DIABETOLOGIA, 2010, 53
  • [37] Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus
    Yoshihara, T
    Kumashiro, N
    Kanazawa, Y
    Mita, T
    Sakurai, Y
    Kawai, J
    Abe, M
    Motojima, K
    Hara, K
    Yamazaki, Y
    Kanazawa, A
    Miwa, S
    Sato, F
    Kanno, R
    Shimizu, T
    Sakai, K
    Uchino, H
    Watada, H
    Tanaka, Y
    Kawamori, R
    Hirose, T
    ENDOCRINE JOURNAL, 2006, 53 (01) : 67 - 72
  • [38] Basal Bolus Insulin Regimens from Diagnosis Improve Honeymoon Period Compared with Twice Daily Mixed Insulin Regimens
    A Gupta
    T Randell
    Pediatric Research, 2011, 70 : 377 - 377
  • [39] BASAL BOLUS INSULIN REGIMENS FROM DIAGNOSIS IMPROVE HONEYMOON PERIOD COMPARED WITH TWICE DAILY MIXED INSULIN REGIMENS
    Gupta, A.
    Randell, T.
    PEDIATRIC RESEARCH, 2011, 70 : 377 - 377
  • [40] The PREFER study: a comparison of outcomes in patients using insulin detemir once daily or twice daily in a basal bolus regimen with mealtime insulin aspart
    Garber, A.
    Binz, K.
    Bergenstal, R.
    Liebl, A.
    DIABETOLOGIA, 2006, 49 : 610 - 610
12345